✦ LIBER ✦

Developments in genetic prodrug activation therapy

Book ID: 120875306
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1998
Weight: 148 KB
Volume: 1119
Category: Article
ISSN: 1173-8324
DOI: 10.1007/BF03314899

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic prodrug activation therapy

✍ LA Martin; R Vile; NR Lemoine; K Sikora; HS Pandha 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 99 KB

Genetic Prodrug Activation Therapy for P

Genetic Prodrug Activation Therapy for Pancreatic Cancer

✍ A. S. RIGG; N. R. LEMOINE 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Cell death associated with genetic prodr

Cell death associated with genetic prodrug activation therapy of colorectal cancer

✍ Stephen Todryk; Alan Melcher; Graham Bottley; Michael Gough; Richard Vile 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 213 KB

The role of adenoviral vectors in geneti

The role of adenoviral vectors in genetic prodrug activation therapy in prostate cancer

✍ Eaton, J D; Clarke, I A; Pandha, H; Dalgleish, A G; Kirby, R S 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 34 KB

Prodrug activation enzymes in cancer gen

Prodrug activation enzymes in cancer gene therapy

✍ Manish Aghi; Fred Hochberg; Xandra O. Breakefield 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

Among the broad array of genes that have been evaluated for tumor therapy, those encoding prodrug activation enzymes are especially appealing as they directly complement ongoing clinical chemotherapeutic regimes. These enzymes can activate prodrugs that have low inherent toxicity using both bacteria

The role of hypoxia-activated prodrugs i

The role of hypoxia-activated prodrugs in cancer therapy

✍ William A Denny 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 223 KB